follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Cyclacel Pharmaceuticals announces $10M underwritten offering

By

Back to Top Comments Email Print

Latest News

    advertisement

    Berkeley Heights-based Cyclacel Pharmaceuticals Inc. announced Friday the pricing of its public offering of 2.857 million shares of common stock at a price of $3.50 per share.

    According to the announcement, the company expects to receive approximately $10 million from the offering.

    Cyclacel has granted underwriters a 30-day option to purchase up to an additional 428,571 shares of stock.  Laidlaw & Company Ltd. is the sole bookrunning manager for the offering, the company said in a recent press release.

    ALSO ON NJBIZ:

    Most-read April 3: Meadowlands Hospital Medical Center names new CEO

    EDA to begin offering N.J. entrepreneurs one-on-one access to investors

    Bergman, Time Equities lease Cherry Hill office space to G.S.A.

    Share This Story On:
    Emily Bader

    Emily Bader

    Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top